Sign In
Buy AVAH
$8.20
+0.280 (+3.54%)
At Close: Jun 23, 2026
Aveanna Healthcare (AVAH) is a Great Momentum Stock: Should You Buy?
01:01pm, Tuesday, 23'rd Jun 2026
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aveanna (AVAH) Is Attractively Priced Despite Fast-paced Momentum
09:56am, Tuesday, 23'rd Jun 2026
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Aveanna (AVAH) could be a great choice. It is one of the several stocks that passed
Why Aveanna (AVAH) Might be Well Poised for a Surge
01:21pm, Monday, 22'nd Jun 2026
Aveanna Healthcare (AVAH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Does Aveanna (AVAH) Have the Potential to Rally 29.01% as Wall Street Analysts Expect?
10:55am, Friday, 19'th Jun 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 29% in Aveanna (AVAH). While the effectiveness of this highly sought-after metric is questionable, the positive
AVAH or CHE: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 10'th Jun 2026
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Aveanna Healthcare (AVAH) and Chemed (CHE). But which of these two stocks presents investors with the b
Best Cheap Stocks Under $10 to Buy Now in June Amid the Market Selloff
04:45pm, Tuesday, 09'th Jun 2026
Bullish investors who want to start buying into market weakness might consider adding highly-ranked cheap stocks trading under $10 per share.
4 Outpatient Home Health Stocks Benefiting From Industry Trends
11:41am, Tuesday, 09'th Jun 2026
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Aveanna Healthcare Raises 2026 Outlook After Family First Deal, Eyes 7%-10% Growth
09:07pm, Tuesday, 02'nd Jun 2026
Aveanna Healthcare NASDAQ: AVAH executives outlined the company's growth strategy, updated 2026 guidance and discussed its newly closed Family First Homecare acquisition during a presentation at Willi
Wall Street Analysts Predict a 50.67% Upside in Aveanna (AVAH): Here's What You Should Know
10:56am, Tuesday, 02'nd Jun 2026
The consensus price target hints at a 50.7% upside potential for Aveanna (AVAH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
Aveanna Healthcare Holdings Completes Acquisition of Family First Homecare and Updates Full Year 2026 Guidance
07:30am, Tuesday, 02'nd Jun 2026
ATLANTA, June 02, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient
Aveanna Healthcare Announces Successful Debt Repricing
08:00am, Thursday, 28'th May 2026
ATLANTA, May 28, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (“Aveanna”) (Nasdaq: AVAH), a leading, diversified home care platform focusing on providing care to medically complex, hi
AVAH vs. CHE: Which Stock Is the Better Value Option?
12:40pm, Monday, 25'th May 2026
Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Aveanna Healthcare (AVAH) or Chemed (CHE). But which of these two stocks is more attra
Aveanna Healthcare: Q1 Results Confirm My Reasons For Optimism
08:57pm, Tuesday, 19'th May 2026
Aveanna Healthcare Holdings reported strong Q1 2026 results, with EPS and revenue significantly beating expectations and shares rising 14% post-earnings. Q1 2026 was the ninth straight quarter in whic
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call Transcript
05:30pm, Thursday, 14'th May 2026
Aveanna Healthcare Holdings Inc. (AVAH) Q1 2026 Earnings Call Transcript
Aveanna Healthcare Q1 Earnings Call Highlights
12:17pm, Thursday, 14'th May 2026
Aveanna Healthcare NASDAQ: AVAH raised its full-year 2026 outlook after reporting double-digit revenue and adjusted EBITDA growth in the first quarter, citing improved reimbursement rates, higher volu
